{
  "compound": "Various (dronabinol, nabilone, nabiximols)",
  "condition": "CANCER_PALLIATIVE",
  "effect_size": "Variable by symptom",
  "study_type": "SYSTEMATIC_REVIEW",
  "source": "NORML:CANCER_SYSTEMATIC_REVIEW_001",
  "participants": "28 studies (N>3,000 patients)",
  "year": 2016,
  "notes": "Cannabinoids for Cancer Symptoms: ASCO Systematic Review",
  "confidence": "medium",
  "abstract": "Pain: Moderate evidence for benefit; Nausea: Strong evidence; Appetite: Moderate evidence; Sleep: Moderate evidence; Evidence grade B for most indications"
}